Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrot...

Full description

Bibliographic Details
Main Authors: Gian Luca Erre, Arduino Aleksander Mangoni
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-01-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/current-therapeutic-strategies-in-connective-tissue-disease-related-interstitial-lung-disease:-introduction-to-the-special-issue
_version_ 1818964217686917120
author Gian Luca Erre
Arduino Aleksander Mangoni
author_facet Gian Luca Erre
Arduino Aleksander Mangoni
author_sort Gian Luca Erre
collection DOAJ
description This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.
first_indexed 2024-12-20T12:57:36Z
format Article
id doaj.art-7ab1d7cac7094cdfb686093b01015125
institution Directory Open Access Journal
issn 1740-4398
1740-4398
language English
last_indexed 2024-12-20T12:57:36Z
publishDate 2021-01-01
publisher BioExcel Publishing Ltd
record_format Article
series Drugs in Context
spelling doaj.art-7ab1d7cac7094cdfb686093b010151252022-12-21T19:40:02ZengBioExcel Publishing LtdDrugs in Context1740-43981740-43982021-01-01101310.7573/dic.2020-12-1Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issueGian Luca ErreArduino Aleksander MangoniThis Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.https://www.drugsincontext.com/current-therapeutic-strategies-in-connective-tissue-disease-related-interstitial-lung-disease:-introduction-to-the-special-issueconnective tissue diseasescyclophosphamideinterstitial lung diseasesmycophenolatenintedanibpierfenidonerituximab
spellingShingle Gian Luca Erre
Arduino Aleksander Mangoni
Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
Drugs in Context
connective tissue diseases
cyclophosphamide
interstitial lung diseases
mycophenolate
nintedanib
pierfenidone
rituximab
title Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_full Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_fullStr Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_full_unstemmed Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_short Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_sort current therapeutic strategies in connective tissue disease related interstitial lung disease introduction to the special issue
topic connective tissue diseases
cyclophosphamide
interstitial lung diseases
mycophenolate
nintedanib
pierfenidone
rituximab
url https://www.drugsincontext.com/current-therapeutic-strategies-in-connective-tissue-disease-related-interstitial-lung-disease:-introduction-to-the-special-issue
work_keys_str_mv AT gianlucaerre currenttherapeuticstrategiesinconnectivetissuediseaserelatedinterstitiallungdiseaseintroductiontothespecialissue
AT arduinoaleksandermangoni currenttherapeuticstrategiesinconnectivetissuediseaserelatedinterstitiallungdiseaseintroductiontothespecialissue